Last week we saw news from Genzyme's (Nasdaq: GENZ) much-awaited annual meeting, in addition to funding news and profiles of start-ups with Boston roots and West Coast backing.


More from

Try any of our Foolish newsletters today, free for 30 days. The Motley Fool has a disclosure policy.

Erin Kutz is an Assistant Editor for Xconomy. You can reach her by email at or by phone at (617) 252-0700.